# clm_84981FD25199

subject: Eli Lilly and Company (/record/eli-lilly.md)  
predicate: total_equity  
value: 14,955,600,000 United States dollar  
valid_from: 2013-03-31  
valid_to: 2013-06-30  
published: 2013-04-26  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_1701758C9C6B  
last_updated: 2026-11-08  
cite: AsOf. "Eli Lilly and Company total equity: 14,955,600,000 United States dollar", as of 2013-03-31 (until 2013-06-30). Claim clm_84981FD25199, https://asof.is/claim/clm_84981FD25199, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/59478/000005947813000019/0000059478-13-000019-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-Q Q1 FY2013, filed 2013-04-26  

## Sources

- https://www.sec.gov/Archives/edgar/data/59478/000005947813000019/0000059478-13-000019-index.htm (primary, SEC EDGAR 10-Q Q1 FY2013, published 2013-04-26)

## Supersedes

- [Eli Lilly and Company](/record/eli-lilly.md) | total_equity | 14,765,200,000 United States dollar | valid 2012-12-31 to 2013-03-31 | conf 0.95 | superseded | superseded_by [clm_84981FD25199](/claim/clm_84981FD25199.md) | [clm_FB9C859803DD](/claim/clm_FB9C859803DD.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.